---
title: "European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/277809914.md"
description: "European equities traded in the US saw American depositary receipts rise 0.82% to 1,778.79 on the S&P Europe Select ADR Index. Notable gainers included Cellectis (CLLS) and Sequans Communications (SQNS), up 5.7% and 5.3%, respectively. Banco Santander (SAN) and BBVA also advanced. Decliners included Evaxion (EVAX) and Anheuser-Busch InBev (BUD). From the UK, Endava (DAVA) and Akari Therapeutics (AKTX) led gains, while Silence Therapeutics (SLN) and Diageo (DEO) were among the decliners. MT Newswires does not provide investment advice."
datetime: "2026-03-04T16:09:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/277809914.md)
  - [en](https://longbridge.com/en/news/277809914.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/277809914.md)
---

# European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading

11:09 AM EST, 03/04/2026 (MT Newswires) -- European equities traded in the US as American depositary receipts were tracking higher late Wednesday morning, rising 0.82% to 1,778.79 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company Cellectis ( CLLS ) and semiconductor company Sequans Communications ( SQNS ) , which rose 5.7% and 5.3% respectively. They were followed by lenders Banco Santander (SAN) and Banco Bilbao Vizcaya Argentaria ( BBVA ) , which advanced 5% and 4.7% respectively.

The decliners from continental Europe were led by biotech firm Evaxion ( EVAX ) and brewing company Anheuser-Busch InBev ( BUD ) , which fell 2.2% and 1.4% respectively. They were followed by pharmaceutical company Sanofi ( SNY ) and consumer goods company Unilever ( UL ) , which were down 0.8% and 0.6% respectively.

From the UK and Ireland, the gainers were led by software firm Endava ( DAVA ) and biopharmaceutical company Akari Therapeutics ( AKTX ) , which increased 8.3% and 7.2% respectively. They were followed by biopharmaceutical company Bicycle Therapeutics ( BCYC ) and biotech firm Autolus Therapeutics ( AUTL ) , which were up 4.1% and 4% respectively.

The decliners from the UK and Ireland were led by pharmaceutical company Silence Therapeutics ( SLN ) and alcoholic beverage company Diageo ( DEO ) , which dropped 4.4% and 3.4% respectively. They were followed by medical device maker Smith & Nephew ( SNN ) and biopharmaceutical company Biodexa Pharmaceuticals ( BDRX ) , which lost 2.2% and 1.1% respectively.

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

### Related Stocks

- [EVAX.US](https://longbridge.com/en/quote/EVAX.US.md)
- [BBVA.US](https://longbridge.com/en/quote/BBVA.US.md)
- [DGE.UK](https://longbridge.com/en/quote/DGE.UK.md)
- [CLLS.US](https://longbridge.com/en/quote/CLLS.US.md)
- [AKTX.US](https://longbridge.com/en/quote/AKTX.US.md)
- [SAN.US](https://longbridge.com/en/quote/SAN.US.md)

## Related News & Research

- [Axactor Buys EUR 3bn Spanish NPL Portfolio From Banco Sabadell](https://longbridge.com/en/news/282139488.md)
- [Jefferies Keeps Their Buy Rating on Diageo (DGEAF)](https://longbridge.com/en/news/282503288.md)
- [03:24 ETEnvision Energy Secures $500M Financing Program with BBVA to Accelerate Global Renewable Deployment](https://longbridge.com/en/news/282305319.md)
- [T1 Energy Announces Pricing of Upsized Public Offering of Convertible Senior Notes Due 2031](https://longbridge.com/en/news/282767072.md)
- [Santander, Webster name key business leaders ahead of merger](https://longbridge.com/en/news/281936990.md)